According to a recent report from the Centers for Disease Control and Prevention, the leading national public health institute of the United States, liver cancer death rates have increased 43 percent.
Although the mortality rate for all cancers combined has declined over 25 years, the age-adjusted liver cancer death rate for U.S. adults 25 and older rose from 7.2 per 100,000 people in 2000 to 10.3 in 2016, the CDC’s National Center for Health Statistics reported.
The liver is the largest internal organ in the human body, and one of the most vital to life, so it is important to keep it healthy and disease free. It is responsible for over 500 functions, including the secretion of glucose, proteins, vitamins, and fats; the production of bile; the processing of hemoglobin; and detoxification of numerous substances.
Several risk factors, including cirrhosis, hepatitis B or hepatitis C, obesity, type 2 diabetes, etc., and an increase in unhealthy lifestyle choices, are being attributed to the rise of liver cancer.
At Rush Radiosurgery, we treat liver cancer with the TrueBeam™ STx Stereotactic Radiosurgery System. TrueBeam™ STx’s ability to treat tumors with precisely focused radiation offers an important advantage for liver cancer patients. Accurate to within less than a millimeter, radiosurgery has minimal effect on surrounding healthy tissue. This level of accuracy enables doctors to target liver tumors with high-dose radiation, which significantly reduces the number of treatments needed, usually between three and five over several days compared to 30-40 over several weeks required for radiotherapy systems.
For more information about how Rush Radiosurgery treats liver cancer, please click here.